iktos logo

iktos

Artificial intelligence for new drug design

85 employees · est. 2016 · Paris, France

VS
Nitto Avecia logo

Nitto Avecia

Comprehensive oligo solutions, from concept to commercial.

601 employees · est. 1995 · Milford, United States

Nitto Avecia is the older company (2016 vs 1995); Nitto Avecia is the larger of the two.

Side-by-Side Comparison

iktos Nitto Avecia
Founded
2016 1995 older
Headquarters
Paris, France Milford, United States
Employees
85 601 larger
Industry
AI, Biotechnology, Health Care Biotechnology, Manufacturing, Pharmaceutical
Funding Stage
Series A Not tracked yet
Total Funding
$18.90M Not tracked yet
Funding Rounds
7 Not tracked yet
Services
AI-driven drug discovery platform, Generative AI for molecular design, Retrosynthesis and synthesis planning, Automated synthesis and testing, Biological data integration Not tracked yet
Target Customers
Pharmaceutical companies, Biotechnology firms, Academic research institutions, Medicinal and computational chemistry teams Not tracked yet
Taxonomy
Artificial Intelligence In Drug Discovery, Generative AI For Molecule Design, MedTech SaaS Solutions, Pharmaceutical R&D Productivity, AI-Driven Synthesis Automation, Oncology Drug Development, Auto-Immune Drug Research, Protein-Protein Interaction Targeting, RNA-Protein Interaction Targeting, Chemoinformatics, Machine Learning In Medicinal Chemistry, Robotics In Drug Discovery, Series A Financing, Strategic Pharma Collaborations, Medicinal Chemistry AI Oligonucleotides, Therapeutics, Pharmaceutical, CMO, Drug Development, Clinical Trials, Biotechnology-based Medicines, Process Validation, Analytical Services, Stability Services, Drug Substance, Drug Product, Clinical Development
Website
iktos.ai avecia.com
iktos logo

About iktos

Iktos, founded in 2016 and headquartered in France, stands at the forefront of leveraging Artificial Intelligence for both medicinal chemistry research and novel drug design. Their slogan, "Artificial intelligence for new drug design," encapsulates their mission. The company offers proprietary SaaS...

Nitto Avecia logo

About Nitto Avecia

Nitto Avecia is a leading player in the oligonucleotide market, offering comprehensive solutions for the development and production of these therapeutics. With over 25 years of experience, the company has positioned itself as a preferred partner for pharmaceutical innovators aiming to revolutionize...

We will tell you when either one moves

BounceWatch watches iktos and Nitto Avecia for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at iktos and Nitto Avecia — by email.

Frequently Asked Questions

iktos — Artificial intelligence for new drug design. Nitto Avecia — Comprehensive oligo solutions, from concept to commercial.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
iktos has raised $18.90M while Nitto Avecia has raised undisclosed funding.
iktos and Nitto Avecia operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare iktos with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at iktos on 20 Aug 2026, and Nitto Avecia on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy